It has not received marketing authorisation from any regulatory body.
Clinical Evidence: What the Research Actually Shows The SUSTAIN-6 trial (semaglutide in type 2 diabetes) documented median LDL reductions of approximately 515% and triglyceride reductions of 2030% in participants with elevated baseline values
They target different receptors involved in Growth Hormone release, creating complementary signaling pathways
Comprehensive Lab Testing Legitimate peptide therapy requires baseline and monitoring labs: Before treatment: Hormone panels, metabolic panels, lipids, inflammatory markers, kidney/liver function During treatment: Regular monitoring of relevant biomarkers (IGF-1 for GH peptides, glucose/HbA1c for GLP-1s) Advanced testing when indicated: DUTCH hormone testing, nutrient panels, genetic markers Why this matters: You cant optimize what you dont measure
Alcohol There is no strict ban on alcohol, but drinking can make side effects like feeling sick worse, and can affect your blood sugar